Tags: Drug.
Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.Amatuximab was developed by Morphotek Inc.Amatuximab is also known as Anti-mesothelin monoclonal antibody MORAb-009. Amatuximab is an anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing and also called MORAb-009.[citation needed]